Gut Microbiome: Both a Friend and a Foe
We Need to Stay on the Gut Microbiome’s Good Side or Risk Microbiota Dysbiosis
Applications of CRISPR/Cas9 Technology in Translational Research on Solid-Tumor Cancers
Efforts Are Underway to Move CRISPR/Cas9 from Bench to Bedside
Flip the DNA Nanoswitch, Power the Clinical App
A Molecular Interaction Detection Platform Uses a Gel-based Readout
Cell Therapy Production Moves to Factory Floor
Assembly Lines Are Preparing to Churn out Safe, Reliable, and Affordable Constructs
For full access to this article login to GEN Select now.
Supplement: Integrated Continuous Manufacturing of Biologics
Biosimilar Manufacturers, Take Note: This Stream Is for You
- Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for drug makers looking to trim manufacturing budgets. But not all biologics would be feasible candidates for a truly integrated ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.